Keywords: Uterus, Uterus, cervical carcinoma; Amide proton transfer imaging； Pathological grading
Motivation: The pathological grading of cervical cancer affects clinical decision-making, and there is currently almost no research on APT for the pathological grading of cervical cancer.
Goal(s): Explore the value of amide proton transfer imaging in evaluating the pathological grading of cervical cancer.
Approach: We delineate the ROI of each parameter and use the final mean for statistics to obtain the results.
Results: The results indicate that APT can be used to evaluate the pathological grading of cervical cancer.
Impact: Pathological grading is the gold standard, and APT has a good evaluation effect on pathological grading of cervical cancer, which is beneficial for clinical doctors to better formulate treatment strategies and serve patients more accurately.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords